Jonathan D. Oliner
Impact in
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- Biotechnology top 0.5%
- Cancer Research and Treatments
Papers in
- Oncology 15
- Cancer-related Molecular Pathways 12
-
- Epigenetics and DNA Methylation 7
- Angiogenesis and VEGF in Cancer 5
- Genomics and Chromatin Dynamics 3
- Co-authors
- Bert VogelsteinKenneth W. KinzlerPaul S. MeltzerDonna L. GeorgeJennifer A. PietenpolJenő GyurisSam ThiagalingamDaniel A. Haber
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Nature (2 papers)Cell (2 papers)Oncotarget (2 papers)Journal of the American College of Cardiology (2 papers)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Jonathan D. Oliner
27 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 3.3k
- Biotechnology 656
- Cancer Research 1.1k
- Molecular Biology 4.2k
- Cell Biology 429
Countries citing papers authored by Jonathan D. Oliner
This map shows the geographic impact of Jonathan D. Oliner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan D. Oliner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan D. Oliner more than expected).
Fields of papers citing papers by Jonathan D. Oliner
This network shows the impact of papers produced by Jonathan D. Oliner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan D. Oliner. The network helps show where Jonathan D. Oliner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan D. Oliner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2016 | 177 | |
| 3 | 2015 | 116 | |
| 4 | 2014 | 5 | |
| 5 | 2014 | 13 | |
| 6 | 2012 | 25 | |
| 7 | 2010 | 192 | |
| 8 | 2010 | 29 | |
| 9 | 2009 | 173 | |
| 10 | 2002 | 34 | |
| 11 | 2002 | 56 | |
| 12 | 2002 | 394 | |
| 13 | E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis Hit paper breakdown → | 2001 | 621 |
| 14 | 1999 | 480 | |
| 15 | 1999 | 241 | |
| 16 | Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Hit paper breakdown → | 1993 | 1227 |
| 17 | 1992 | 9 | |
| 18 | Amplification of a gene encoding a p53-associated protein in human sarcomas Hit paper breakdown → | 1992 | 1638 |
| 19 | 1991 | 34 | |
| 20 | 1989 | 150 |
About Jonathan D. Oliner
Jonathan D. Oliner is a scholar working on Oncology, Molecular Biology, Cancer Research, Biotechnology and Cardiology and Cardiovascular Medicine, having authored 28 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Epigenetics and DNA Methylation (7 papers), Angiogenesis and VEGF in Cancer (5 papers), Genomics and Chromatin Dynamics (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Lipid metabolism and disorders (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (3.3k citations), Biotechnology (656 citations), Cancer Research (1.1k citations), Molecular Biology (4.2k citations) and Cell Biology (429 citations). Jonathan D. Oliner has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Bert Vogelstein, Kenneth W. Kinzler, Paul S. Meltzer, Donna L. George, Jennifer A. Pietenpol, Jenő Gyuris, Sam Thiagalingam, Daniel A. Haber, Fred C. Christians and Leif W. Ellisen. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Nature, Cell, Oncotarget and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.